It was reported on 4 February 2015, that CTI BioPharma Corp. (NASDAQ:CTIC) announced that the Gynecologic Oncology Group, now part of NRG Oncology, informed CTI BioPharma that an independent Data Monitoring Committee (DMC) recommended continuation of the GOG-0212 phase 3 clinical study of Opaxio (paclitaxel poliglumex) as maintenancetherapy in ovarian cancer with no changes following a second of four planned interim analyses for survival and futility. CTI BioPharma remains blinded to the interim analysis results. GOG-0212 is the largest maintenance study in this setting, having enrolled 1,150 patients. On Tuesday shares of CTI BioPharma Corp. (NASDAQ:CTIC) closed at $2.22. Company’s sales growth for last 5 years was 24.90%.
Hanwha Solarone Co Ltd (NASDAQ:HSOL) has completed the acquisition of Hanwha Q CELLS, which will result in Hanwha Q CELLS adopting the formal name Hanwha Q CELLS Co., Ltd. and will trade on the NASDAQ under the symbol HQCL. On Tuesday shares of Hanwha Solarone Co Ltd (NASDAQ:HSOL) closed at $1.10.
On 5 February 2015, Callidus Software, Inc. (NASDAQ: CALD) reported Q4 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $38.1 million versus the consensus estimate of $35.9 million. Callidus Software, Inc. sees Q1 2015 EPS of $0.04-$0.06, versus the consensus of $0.05. Callidus Software, Inc. sees Q1 2015 revenue of $38-39 million, versus the consensus of $37.44 million. On last trading day Callidus Software Inc. (NASDAQ:CALD) moved down -0.77% to close at $15.43. Its volatility for the week is 4.93% while volatility for the month is 4.18%. CALD’s sales growth for past 5 years was 11.00% and its EPS growth for past 5 years was 16.70%. Callidus Software Inc. (NASDAQ:CALD) monthly performance is 0.92%.
It was reported on 7 February 2015, that General Electric Company (NYSE:GE) is in the midst of filling a $2.7 billion order for power generation equipment from Algeria, including massive steam turbines being built at its factory in Schenectady. On Tuesday shares of General Electric Company (NYSE:GE) closed at $24.72. Company’s sales growth for last 5 years was -0.80% and EPS growth for next 5 years is recorded as 7.41%.
On 27 January 2015, Key Tronic Corp. (NASDAQ:KTCC); reported Q2 EPS of $0.12, versus $0.14 reported last year. Revenue for the quarter came in at $114.3 million, versus $78.3 million reported last year. On last trading day Key Tronic Corp. (NASDAQ:KTCC) increased 0.10% to close at $9.62. Its volatility for the week is 3.32% while volatility for the month is 3.43%. KTCC’s sales growth for past 5 years was 10.60% and its EPS growth for past 5 years was 43.50%. Key Tronic Corp. (NASDAQ:KTCC) monthly performance is 12.91%.